By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Neogenix Oncology, Inc. 

445 Northern Boulevard

Great Neck  New York  11021  U.S.A.
Phone: 516-482-1200 Fax: 516-482-3848




Company News
Neogenix Oncology, Inc.'s Novel Antibody NEO-101 Named One of Windhover Information Inc.'s Top 10 Projects to Watch 11/30/2011 8:55:38 AM
Neogenix Oncology, Inc. and Cambridge Biomedical Inc. Form a Partnership for Development of Blood Based Cancer Diagnostic Tests 6/16/2011 8:57:02 AM
Neogenix Oncology, Inc. Announces Enhancement of Management Consulting Team 6/14/2011 9:33:53 AM
Data on Neogenix Oncology, Inc.’s Phase I Study of Novel Therapeutic Antibody NPC-1C (Ensituximab) to be Presented at American Society of Clinical Oncology’s 2011 Annual Meeting 6/3/2011 8:10:00 AM
Neogenix Oncology, Inc. Obtains Patent in Europe Relating to Its NEO-301 Antibody 5/12/2011 11:08:00 AM
Neogenix Oncology, Inc. to Hold Conference Call to Discuss 2010 Financial Results and Company Highlights 4/7/2011 9:23:14 AM
Neogenix Oncology, Inc. Hires Dr. Albine Martin as Chief Operating Officer 2/17/2011 10:38:08 AM
Neogenix Oncology, Inc. Will Present Data on a New Stool Biomarker Test for the Detection of Colorectal Cancer at American Society of Clinical Oncology's 2011 Gastrointestinal Cancers Symposium 1/19/2011 10:39:33 AM
Selexis SA and Neogenix Oncology, Inc. Execute Commercial License Agreement 1/12/2011 11:05:25 AM
Neogenix Oncology, Inc. Receives Additional Federal Grant, Bringing Total Award to Over $730,000 1/6/2011 11:04:55 AM